Latest Findings on Hydrogel Drug Delivery Systems in the Treatment of Periodontitis
Abstract
Hydrogel drug delivery systems possess unique structures and properties and hence can be injected and retained in the periodontal pocket for slow and controlled release of medications with antibacterial, anti-inflammatory, and periodontal tissue regeneration-promotional effects. Due to their safety, practicability, and effectiveness, they show great potential in the treatment of periodontitis. In this paper, we gave an overview of hydrogel drug delivery systems in the treatment of periodontitis, summing up the classification and forms of the drugs delivered and the strengths and weaknesses of common types of hydrogel matrixes. In addition, we discussed properties required for hydrogel drug delivery systems applicable in the treatment of periodontitis, including a certain level of viscosity, suitable degradation cycle, and temperature sensitivity. Finally, we summarized the stimulus responsiveness types of hydrogel drug delivery systems applicable in the treatment of periodontitis, including pH-responsiveness, enzyme-responsiveness, reactive oxygen species-responsiveness, light-responsiveness, and sugar-responsiveness. In the future, researchers should make further investigation into the clinical efficacy of hydrogel drug delivery systems and promote their translation into clinical applications. Additionally, hydrogel drug delivery systems carrying biologic drugs could be further investigated to promote advancement in the field of periodontal tissue regeneration. Furthermore, the response sources, realization strategies, and safe preparation methods of smart hydrogel drug delivery systems should also be further clarified and explored to achieve drug delivery of better efficiency and safety. In addition to drug delivery, hydrogel matrixes with medicinal values also show great promises.
Keywords: Hydrogel, Drug delivery systems, Periodontitis, Review
Full Text:
PDFReferences
KWON T, LAMSTER I B, LEVIN L. Current concepts in the management of periodontitis. Int Dent J,2021,71(6): 462–476. doi: 10. 1111/idj.12630.
LIU Y, LIU C, WANG C, et al. Treatment of periodontal inflammation in diabetic rats with IL-1ra thermosensitive hydrogel. Int J Mol Sci,2022, 23(22): 13939. doi: 10.3390/ijms232213939.
LIU Y, LI T, SUN M, et al. ZIF-8 modified multifunctional injectable photopolymerizable GelMA hydrogel for the treatment of periodontitis. Acta Biomater,2022,146: 37–48. doi: 10.1016/j.actbio.2022.03.046.
SMILEY C J, TRACY S L, ABT E, et al. Evidence-based clinical practice guideline on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc, 2015,146(7): 525–535. doi: 10.1016/j.adaj.2015.01.026.
LIU L, WU D, TU H, et al. Applications of hydrogels in drug delivery for oral and maxillofacial diseases. Gels,2023,9(2): 146. doi: 10.3390/gels9020146.
BOONLAI W, TANTISHAIYAKUL V, HIRUN N, et al. Thermosensitive poloxamer 407/poly(acrylic acid) hydrogels with potential application as injectable drug delivery system. AAPS Pharm Sci Tech,2018,19(5): 2103–2117. doi: 10.1208/s12249-018-1010-7.
WONG P Y, SOO S, WONG E S, et al. A novel antimicrobial hydrogel for the management of periodontal diseases. Int Dent J,2023,73(3): 354–361. doi: 10.1016/j.identj.2023.01.002.
QI Y, YANG J, CHI Y, et al. Natural polyphenol self-assembled pH-responsive nanoparticles loaded into reversible hydrogel to inhibit oral bacterial activity. Mol Biomed,2022,3(1): 28. doi: 10.1186/s43556-022-00082-3.
LI N, XIE L, WU Y, et al. Dexamethasone-loaded zeolitic imidazolate frameworks nanocomposite hydrogel with antibacterial and anti-inflammatory effects for periodontitis treatment. Mater Today Bio,2022, 16: 100360. doi: 10.1016/j.mtbio.2022.100360.
XU X, GU Z, CHEN X, et al. An injectable and thermosensitive hydrogel: promoting periodontal regeneration by controlled-release of aspirin and erythropoietin. Acta Biomater,2019,86: 235–246. doi: 10. 1016/j.actbio.2019.01.001.
CHEN N, REN R, WEI X, et al. Thermoresponsive hydrogel-based local delivery of simvastatin for the treatment of periodontitis. Mol Pharm, 2021,18(5): 1992–2003. doi: 10.1021/acs.molpharmaceut.0c01196.
ALMOSHARI Y, REN R, ZHANG H, et al. GSK3 inhibitor-loaded osteotropic pluronic hydrogel effectively mitigates periodontal tissue damage associated with experimental periodontitis. Biomaterials,2020, 261: 120293. doi: 10.1016/j.biomaterials.2020.120293.
ZHAO X, YANG Y, YU J, et al. Injectable hydrogels with high drug loading through B-N coordination and ROS-triggered drug release for efficient treatment of chronic periodontitis in diabetic rats. Biomaterials, 2022,282: 121387. doi: 10.1016/j.biomaterials.2022.121387.
SHEN Z, KUANG S, ZHANG Y, et al. Chitosan hydrogel incorporated with dental pulp stem cell-derived exosomes alleviates periodontitis in mice via a macrophage-dependent mechanism. Bioact Mater,2020,5(4): 1113–1126. doi: 10.1016/j.bioactmat.2020.07.002.
GOTO R, NISHIDA E, KOBAYASHI S, et al. Gelatin methacryloyl- riboflavin (gelma-RF) hydrogels for bone regeneration. Int J Mol Sci, 2021,22(4): 1635. doi: 10.3390/ijms22041635.
LIU J, LIU H, JIA Y, et al. Glucose-sensitive delivery of tannic acid by a photo-crosslinked chitosan hydrogel film for antibacterial and anti-inflammatory therapy. J Biomater Sci Polym Ed,2022,33(13): 1644–1663. doi: 10.1080/09205063.2022.2068948.
MA S, LU X, YU X, et al. An injectable multifunctional thermo-sensitive chitosan-based hydrogel for periodontitis therapy. Biomater Adv,2022,142: 213158. doi: 10.1016/j.bioadv.2022.213158.
WANG H, CHANG X, MA Q, et al. Bioinspired drug-delivery system emulating the natural bone healing cascade for diabetic periodontal bone regeneration. Bioact Mater,2023,21: 324–339. doi: 10.1016/j.bioactmat. 2022.08.029.
DONG Z, SUN Y, CHEN Y, et al. Injectable adhesive hydrogel through a microcapsule cross-link for periodontitis treatment. ACS Appl Bio Mater,2019,2(12): 5985–5994. doi: 10.1021/acsabm.9b00912.
AMINU N, CHAN S Y, YAM M F, et al. A dual-action chitosan-based nanogel system of triclosan and flurbiprofen for localised treatment of periodontitis. Int J Pharm,2019,570: 118659. doi: 10.1016/j.ijpharm. 2019.118659.
LI M, LV J, YANG Y, et al. Advances of hydrogel therapy in periodontal regeneration-a materials perspective review. Gels,2022,8(10): 624. doi: 10.3390/gels8100624.
GAO H, WU N, WANG N, et al. Chitosan-based therapeutic systems and their potentials in treatment of oral diseases. Int J Biol Macromol, 2022,222: 3178–3194. doi: 10.1016/j.ijbiomac.2022.10.090.
PHAM D T, PHEWCHAN P, NAVESIT K, et al. Development of metronidazole-loaded in situ thermosensitive hydrogel for periodontitis treatment. Turk J Pharm Sci,2021,18(4): 510–516. doi: 10.4274/tjps. galenos.2020.09623.
ZUSSMAN M, ZILBERMAN M. Injectable metronidazole-eluting gelatin-alginate hydrogels for local treatment of periodontitis. J Biomater Appl,2022,37(1): 166–179. doi: 10.1177/08853282221079458.
LACROCE E, ROSSI F. Polymer-based thermoresponsive hydrogels for controlled drug delivery. Expert Opin Drug Deliv,2022,19(10): 1203–1215. doi: 10.1080/17425247.2022.2078806.
Refbacks
- There are currently no refbacks.



